Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

GM Pharma International Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (341)

Date

2024 (106)
2023 (5)
2022 (2)
2021 (6)
2020 (56)
2019 (6)
2018 (17)
2017 (19)
2016 (17)
2015 (19)
2014 (13)
2013 (16)
2012 (16)
2011 (14)
2010 (4)
2009 (13)
2007 (7)
2006 (4)
2005 (1)

Results for "[search-keyword]"

Search

Sponsor content

341 result(s) found, displaying 341 to 341

TERBINAFINE-WGR terbinafine 250mg (as hydrochloride) tablet blister pack (100028)

15 April 2005

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TERBINAFINE-WGR terbinafine 250mg (as hydrochloride) tablet blister pack.

Pages

First page
Previous page
…
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Current page 35

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

GM Pharma International Pty Ltd

Type

Date

TERBINAFINE-WGR terbinafine 250mg (as hydrochloride) tablet blister pack (100028)

Help us improve the Therapeutic Goods Administration site